10 most recent filings and news items mentioning ASPI. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ASPI/news?limit=20"
Pull ASPI filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayASP Isotopes announced it will host investor meetings at Citi's 2026 Natural Resources Conference in Las Vegas on August 13, 2026. The announcement also covers a proposed merger with Endra Life Sciences.
View filing at SEC.gov →ASP Isotopes initiatives targeting critical materials are progressing, with revenue expectations for 1H 2026 increasing by more than 50% and the company achieving key inflection points. The news reinforces the company's bullish outlook regarding profitability and long-term EBITDA
View filing at SEC.gov →ASP Isotopes announced CCO Viktor Petkov will speak at the Canaccord Genuity Growth Conference on August 12, 2026. This provides investors with an update on the company's differentiated isotope enrichment platforms and upcoming Proposed Transactions.
View filing at SEC.gov →ASP Isotopes announced its first-ever Capital Markets Day in London on September 8 to provide an overview of its strategy in critical materials. The event will focus on nuclear medicine, electronic gases, and nuclear fuels, and is intended to bolster investor interest in its prop
View filing at SEC.gov →ASP Isotopes' subsidiary Quantum Leap Energy signed a research agreement with Texas A&M, aiming to de-risk and scale the commercial production of uranium hexafluoride for the U.S. nuclear fuel supply chain.
View filing at SEC.gov →EisnerAmper LLP granted consent to incorporate its audit report into ASP Isotopes' S-3 and S-8 registration statements. This administrative filing supports the company's ongoing capital-raising objectives.
View filing at SEC.gov →ASP Isotopes Inc. and partners entered into a definitive agreement on a merger plan. The transaction is set to close in June 2026.
View filing at SEC.gov →ASP Isotopes subsidiary Noble Africa proposed merging with ENDRA Life Sciences subsidiary to form a Nasdaq-listed helium platform under ticker NOBA, backed by $50 million in financing. The deal establishes a public market vehicle for Renergen's helium project amid supply constrai
View filing at SEC.gov →Renergen, an ASP subsidiary, signed a five-year take-or-pay contract with an Asian buyer for helium at prices above $600/MCF, ensuring cash flow for Phase 1 operations. The agreement de-risks the 2026 commercial timeline and strengthens ASP's position in the critical materials ma
View filing at SEC.gov →ASP Isotopes successfully restarted the first 18 stages of its Silicon-28 enrichment facility after nine months of engineering modifications to non-core components. The company expects to commence commercial shipments of enriched Silicon-28 in Q3 2026 to three U.S. customers, wit
View filing at SEC.gov →